BCV
BIIB icon

Banque Cantonale Vaudoise’s Biogen BIIB Stock Holding History

Banque Cantonale Vaudoise’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.45M Buy
7,928
+4,466
+129% +$823K 0.05% 314
2025
Q4 		$609K Sell
3,462
-11,683
-77% -$1.91M 0.02% 429
2025
Q3 		$2.12M Sell
15,145
-3,335
-18% -$451K 0.08% 245
2025
Q2 		$2.32M Buy
18,480
+8,648
+88% +$1.08M 0.09% 214
2025
Q1 		$1.34M Buy
+9,832
New +$1.41M 0.06% 302
2024
Q3 		$1.02M Sell
5,259
-2,059
-28% -$431K 0.04% 318
2024
Q2 		$1.7M Buy
7,318
+4,401
+151% +$956K 0.07% 262
2024
Q1 		$630K Sell
2,917
-1,505
-34% -$352K 0.02% 403
2023
Q4 		$1.15M Sell
4,422
-1,391
-24% -$342K 0.05% 317
2023
Q3 		$1.5M Sell
5,813
-659
-10% -$176K 0.07% 221
2023
Q2 		$1.84M Buy
6,472
+336
+5% +$100K 0.09% 200
2023
Q1 		$1.71M Buy
6,136
+200
+3% +$55.3K 0.08% 228
2022
Q4 		$1.64M Sell
5,936
-611
-9% -$173K 0.09% 215
2022
Q3 		$1.75M Buy
6,547
+2
+0% +$425 0.1% 196
2022
Q2 		$1.33M Sell
6,545
-1,152
-15% -$235K 0.07% 278
2022
Q1 		$1.62M Sell
7,697
-161
-2% -$35K 0.07% 272
2021
Q4 		$1.89M Sell
7,858
-388
-5% -$99.8K 0.07% 251
2021
Q3 		$2.33M Buy
8,246
+280
+4% +$91.8K 0.1% 194
2021
Q2 		$2.76M Sell
7,966
-1,110
-12% -$336K 0.12% 174
2021
Q1 		$2.54M Buy
9,076
+2,026
+29% +$546K 0.13% 160
2020
Q4 		$1.73M Sell
7,050
-123
-2% -$31.7K 0.1% 192
2020
Q3 		$2.04M Sell
7,173
-2,008
-22% -$560K 0.13% 144
2020
Q2 		$2.46M Buy
9,181
+2,100
+30% +$631K 0.18% 118
2020
Q1 		$2.24M Buy
7,081
+2,000
+39% +$607K 0.19% 110
2019
Q4 		$1.51M Buy
+5,081
New +$1.41M 0.1% 221

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Banque Cantonale Vaudoise's BIIB Position: Q1 2026 in Review

Banque Cantonale Vaudoise increased its Biogen (BIIB) stake by 129% in Q1 2026, buying an estimated $823K and bringing the position to 7,928 shares worth $1.45M. The position accounts for 0.05% of the portfolio, ranked #314.

Banque Cantonale Vaudoise first reported a position in BIIB in Q4 2019 and has held it in 25 quarters since. The position peaked at $2.76M in Q2 2021. 1,002 funds tracked by Wall St. Rank hold BIIB as of Q1 2026.

  • Banque Cantonale Vaudoise held 7,928 shares of Biogen worth $1.45M as of Q1 2026.
  • Banque Cantonale Vaudoise bought 4,466 Biogen shares in Q1 2026, an estimated $823K.
  • Biogen made up 0.05% of Banque Cantonale Vaudoise's portfolio in Q1 2026, its #314 holding.
  • Banque Cantonale Vaudoise first reported a position in Biogen in Q4 2019 and has held it in 25 quarters since.
  • Banque Cantonale Vaudoise's Biogen position peaked at $2.76M in Q2 2021.
  • 1,002 funds tracked by Wall St. Rank held Biogen as of Q1 2026.

Based on Banque Cantonale Vaudoise's 13F filing for Q1 2026, filed 20 Apr 2026.